Literature DB >> 20850781

Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury.

Michael D Goodman1, Amy T Makley, Nathan L Huber, Callisia N Clarke, Lou Ann W Friend, Rebecca M Schuster, Stephanie R Bailey, Stephen L Barnes, Warren C Dorlac, Jay A Johannigman, Alex B Lentsch, Timothy A Pritts.   

Abstract

OBJECTIVE: To determine the inflammatory effects of time-dependent exposure to the hypobaric environment of simulated aeromedical evacuation following traumatic brain injury (TBI).
METHODS: Mice were subjected to a blunt TBI or sham injury. Righting reflex response (RRR) time was assessed as an indicator of neurologic recovery. Three or 24 h (Early and Delayed groups, respectively) after TBI, mice were exposed to hypobaric flight conditions (Fly) or ground-level control (No Fly) for 5 h. Arterial blood gas samples were obtained from all groups during simulated flight. Serum and cortical brain samples were analyzed for inflammatory cytokines after flight. Neuron specific enolase (NSE) was measured as a serum biomarker of TBI severity.
RESULTS: TBI resulted in prolonged RRR time compared with sham injury. After TBI alone, serum levels of interleukin-6 (IL-6) and keratinocyte-derived chemokine (KC) were increased by 6 h post-injury. Simulated flight significantly reduced arterial oxygen saturation levels in the Fly group. Post-injury altitude exposure increased cerebral levels of IL-6 and macrophage inflammatory protein-1α (MIP-1α), as well as serum NSE in the Early but not Delayed Flight group compared to ground-level controls.
CONCLUSIONS: The hypobaric environment of aeromedical evacuation results in significant hypoxia. Early, but not delayed, exposure to a hypobaric environment following TBI increases the neuroinflammatory response to injury and the severity of secondary brain injury. Optimization of the post-injury time to fly using serum cytokine and biomarker levels may reduce the potential secondary cerebral injury induced by aeromedical evacuation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20850781      PMCID: PMC4607063          DOI: 10.1016/j.jss.2010.05.055

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  37 in total

1.  Association between acute hypobaric hypoxia and activation of coagulation in human beings.

Authors:  B Bendz; M Rostrup; K Sevre; T O Andersen; P M Sandset
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

2.  High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein.

Authors:  G Hartmann; M Tschöp; R Fischer; C Bidlingmaier; R Riepl; K Tschöp; H Hautmann; S Endres; M Toepfer
Journal:  Cytokine       Date:  2000-03       Impact factor: 3.861

3.  Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes.

Authors:  T Kossmann; V Hans; H G Imhof; O Trentz; M C Morganti-Kossmann
Journal:  Brain Res       Date:  1996-03-25       Impact factor: 3.252

4.  Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients.

Authors:  Thomas Mussack; Peter Biberthaler; Karl Georg Kanz; Ute Heckl; Rudolf Gruber; Ulrich Linsenmaier; Wolf Mutschler; Marianne Jochum
Journal:  Shock       Date:  2002-11       Impact factor: 3.454

5.  Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans.

Authors:  M Arand; H Melzner; L Kinzl; U B Brückner; F Gebhard
Journal:  Langenbecks Arch Surg       Date:  2001-07       Impact factor: 3.445

6.  Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients.

Authors:  Christian Woiciechowsky; Britta Schöning; Jacqueline Cobanov; Wolfgang R Lanksch; Hans-Dieter Volk; Wolf-Dieter Döcke
Journal:  J Trauma       Date:  2002-02

7.  Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury.

Authors:  Aslan Guzel; Uygur Er; Mehmet Tatli; Ufuk Aluclu; Umit Ozkan; Yucel Duzenli; Omer Satici; Ebru Guzel; Serdar Kemaloglu; Adnan Ceviz; Abdurrahman Kaplan
Journal:  Neurosurg Rev       Date:  2008-06-17       Impact factor: 3.042

8.  Changes of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 in brain and plasma after brain injury in rats.

Authors:  Tao Zhu; Zhi Yao; Han-na Yuan; Bo-gang Lu; Shu-yuan Yang
Journal:  Chin J Traumatol       Date:  2004-02

9.  Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries.

Authors:  T Kossmann; V H Hans; H G Imhof; R Stocker; P Grob; O Trentz; C Morganti-Kossmann
Journal:  Shock       Date:  1995-11       Impact factor: 3.454

Review 10.  Modulation of immune response by head injury.

Authors:  Maria Cristina Morganti-Kossmann; Laveniya Satgunaseelan; Nicole Bye; Thomas Kossmann
Journal:  Injury       Date:  2007-11-28       Impact factor: 2.586

View more
  19 in total

1.  A mouse model of human repetitive mild traumatic brain injury.

Authors:  Michael J Kane; Mariana Angoa-Pérez; Denise I Briggs; David C Viano; Christian W Kreipke; Donald M Kuhn
Journal:  J Neurosci Methods       Date:  2011-09-12       Impact factor: 2.390

2.  Can we optimize long-term outcomes in acute respiratory distress syndrome by targeting normoxemia?

Authors:  Mark E Mikkelsen; Brian Anderson; Jason D Christie; Ramona O Hopkins; Paul N Lanken
Journal:  Ann Am Thorac Soc       Date:  2014-05

3.  17β-estradiol alters mRNA co-expression after murine muscle injury and mild hypobaria.

Authors:  Scott Emory Moore; Joachim G Voss; Barbara St Pierre Schneider
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-18

4.  Simulated aeromedical evacuation does not affect systemic inflammation or organ injury in a murine model of hemorrhagic shock.

Authors:  Amy T Makley; Ritha Belizaire; Eric M Campion; Michael D Goodman; Dennis I Sonnier; Lou Ann Friend; Rebecca M Schuster; Stephanie R Bailey; Jay A Johannigman; Warren C Dorlac; Alex B Lentsch; Timothy A Pritts
Journal:  Mil Med       Date:  2012-08       Impact factor: 1.437

5.  Post-traumatic hypoxia exacerbates neuronal cell death in the hippocampus.

Authors:  Jun-feng Feng; Xueren Zhao; Gene G Gurkoff; Ken C Van; Kiarash Shahlaie; Bruce G Lyeth
Journal:  J Neurotrauma       Date:  2012-01-30       Impact factor: 5.269

6.  UCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma.

Authors:  Mackenzie C Morris; Aron Bercz; Grace M Niziolek; Farzaan Kassam; Rose Veile; Lou Ann Friend; Timothy A Pritts; Amy T Makley; Michael D Goodman
Journal:  J Surg Res       Date:  2019-07-03       Impact factor: 2.192

7.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

Review 8.  Traumatic brain injury using mouse models.

Authors:  Yi Ping Zhang; Jun Cai; Lisa B E Shields; Naikui Liu; Xiao-Ming Xu; Christopher B Shields
Journal:  Transl Stroke Res       Date:  2014-02-05       Impact factor: 6.829

9.  NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia.

Authors:  Gene G Gurkoff; Jun-Feng Feng; Ken C Van; Ali Izadi; Rahil Ghiasvand; Kiarash Shahlaie; Minsoo Song; David A Lowe; Jia Zhou; Bruce G Lyeth
Journal:  Brain Res       Date:  2013-04-03       Impact factor: 3.252

10.  Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice.

Authors:  Sung H Yang; Matt Gangidine; Timothy A Pritts; Michael D Goodman; Alex B Lentsch
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.